Press Releases

Year

Feb 2007

LIFEVANTAGE CORPORATION SCHEDULES 2ND QUARTER FY 2007 EARNINGS CONFERENCE CALL

GREENWOOD VILLAGE, Colo.--(BUSINESS WIRE)--LifeVantage Corporation (OTCBB: LFVN), formerly Lifeline Therapeutics, Inc., maker of Protandim®, will hold a conference call on Tuesday, February 13, 2007 at 8:00 a.m. MT (10:00 a.m. ET) to discuss its second quarter fiscal year 2007 financial and

PDF Version

Jan 2007

LIFEVANTAGE CORPORATION ANNOUNCES REGISTRATION STATEMENT EFFECTIVE

LIFEVANTAGE CORPORATION ANNOUNCES REGISTRATION STATEMENT EFFECTIVE GREENWOOD VILLAGE, Colorado – LifeVantage Corporation, formerly Lifeline Therapeutics, Inc. (the "Company") (LFLT.OB), announced that its Registration Statement on Form SB-2, relating to the resale of 6,322,001 shares of common

PDF Version

Dec 2006

LIFEVANTAGE CORPORATION ANNOUNCES APPOINTMENT OF JAMES J. KREJCI AS CEO AND OTHER BOARD CHANGES

LIFEVANTAGE CORPORATION ANNOUNCES APPOINTMENT OF JAMES J. KREJCI AS CEO AND OTHER BOARD CHANGES DENVER, Colorado – Lifevantage Corporation (OTCBB: LFLT), maker of Protandim®, today announced that Mr. James J. Krejci has been appointed Chief Executive Officer by the Board of Directors. Mr.

PDF Version

Dec 2006

LIFEVANTAGE CORPORATION ANNOUNCES CEO AND BOARD CHANGES

LIFEVANTAGE CORPORATION ANNOUNCES CEO AND BOARD CHANGES DENVER, Colorado – Lifevantage Corporation (OTCBB: LFLT), maker of Protandim®, today announced that Mr. Stephen K. Onody has resigned as Chief Executive Officer and as a member of the Board of Directors effective December 15, 2006. Mr.

PDF Version

Dec 2006

LIFEVANTAGE CORPORATION ANNOUNCES drugstore.com, inc. TO CARRY PROTANDIM®

DENVER, Colorado – Lifevantage Corporation (OTCBB: LFLT), maker of Protandim®, today announced the launch of Protandim® on the drugstore.com™ Web store. "We are pleased to add drugstore.com, inc. to our list of partners ", said Stephen K. Onody, Chief Executive Officer of Lifevantage.

PDF Version

Dec 2006

LIFELINE THERAPEUTICS, INC. CHANGES NAME TO LIFEVANTAGE CORPORATION

LIFELINE THERAPEUTICS, INC. CHANGES NAME TO LIFEVANTAGE CORPORATION DENVER, Colorado – Lifevantage Corporation (OTCBB: LFLT), maker of Protandim®, today announced that at its annual meeting of shareholders held on November 21, 2006, shareholders approved Amended and Restated Articles of

PDF Version

Dec 2006

LIFEVANTAGE CORPORATION ANNOUNCES ADDITIONAL STUDIES INVOLVING PROTANDIM®

DENVER, Colorado – Lifevantage Corporation, formerly Lifeline Therapeutics, Inc. (OTCBB: LFLT), maker of Protandim®, announced today that Protandim® has been made available to independent investigators engaged in human clinical and laboratory studies designed to investigate the ability of

PDF Version

Nov 2006

LIFELINE THERAPEUTICS, INC. TO RESTATE FINANCIALS TO REFLECT INVESTMENT IN PATENTS AND OTHER ITEMS

LIFELINE THERAPEUTICS, INC. TO RESTATE FINANCIALS TO REFLECT INVESTMENT IN PATENTS AND OTHER ITEMS DENVER, Colorado – Lifeline Therapeutics, Inc. (OTCBB: LFLT), maker of Protandim®, today announced that it intends to restate certain of its previously filed financial statements to reflect changes to

PDF Version

Nov 2006

LIFELINE THERAPEUTICS, INC. TO RECOGNIZE PREVIOUSLY DEFERRED RETAIL CHAIN REVENUE

DENVER, Colorado – Lifeline Therapeutics, Inc. (OTCBB: LFLT), maker of Protandim®, announced today that it will recognize previously deferred revenue and costs related to its retail partner, GNC. As previously disclosed, revenue under this contract had been deferred due to minimal sales history.

PDF Version

Nov 2006

LIFELINE THERAPEUTICS, INC. ANNOUNCES 1Q FY2007 FINANCIAL AND OPERATING RESULTS

DENVER, Colorado -- Lifeline Therapeutics, Inc. (OTCBB: LFLT), maker of Protandim®, today announced results for its first quarter, fiscal year 2007 ended September 30, 2006. The Company recorded net revenues of $2.1 million and a loss of $(820,208), or $(0.04) per share.

PDF Version

Pagination

First page
Previous page
…
Page 40
Page 41
Page 42
Page 43
Current page 44
Page 45
Page 46
Page 47
Page 48
Next page
Last page